Crystal structure of mouse mu-crystallin complexed with NADPH and the T3 thyroid hormone

FEBS Journal

Volumn 281, Issue 6, 2014, Pages 1598-1612

  Borel, Franck ^a   Hachi, Isma ^a   Palencia, Andres ^a   Gaillard, Marie Claude ^b   Ferrer, Jean Luc ^a,c  

^a UNIV GRENOBLE ALPES   (France)

^b Molecular Imaging Research Center   (France)

^c INSTITUT DE BIOLOGIE STRUCTURALE   (France)

Author keywords

in silico docking; isothermal titration calorimetry; ketimine reductase; mu crystallins; thyroid hormone binding; X ray crystal structure

Indexed keywords

IN SILICO DOCKING; ISOTHERMAL TITRATION CALORIMETRY; KETIMINE REDUCTASE; MU-CRYSTALLINS; THYROID HORMONE BINDING; X-RAY CRYSTAL STRUCTURE;

ANIMALS; APOPROTEINS; BINDING SITES; CALORIMETRY; COMPUTER SIMULATION; CRYSTALLINS; CRYSTALLOGRAPHY, X-RAY; LIGANDS; MICE; MODELS, MOLECULAR; NADP; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; STATIC ELECTRICITY; THERMODYNAMICS; TRIIODOTHYRONINE;

EID: 84899422695     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12726     Document Type: Article

References (33)

1. Kim RY, Gasser R, &, Wistow GJ, (1992) Mu-crystallin is a mammalian homologue of Agrobacterium ornithine cyclodeaminase and is expressed in human retina. Proc Natl Acad Sci U S A 89, 9292-9296.
2. Graw J, (2009) Genetics of crystallins: cataract and beyond. Exp Eye Res 88, 173-189.
3. Vié M-P, Evrard C, Osty J, Breton-Gilet A, Blanchet P, Pomerance M, Rouget P, Francon J, &, Blondeau J-P, (1997) Purification, molecular cloning, and functional expression of the human nicodinamide-adenine dinucleotide phosphate-regulated thyroid hormone-binding protein. Mol Endocrinol 11, 1728-1736. (Pubitemid 27435420)
4. Suzuki S, Suzuki N, Mori J, Oshima A, Usami S, &, Hashizume K, (2007) Micro-crystallin as an intracellular 3,5,3′-triiodothyronine holder in vivo. Mol Endocrinol 4, 885-894. (Pubitemid 46984729)
5. Suzuki S, Mori J, &, Hashizume K, (2007) Mu-crystallin, a NADPH-dependent T(3)-binding protein in cytosol. Trends Endocrinol Metab 18, 286-289. (Pubitemid 47332215)
6. Hallen A, Cooper AJ, Jamie JF, Haynes PA, &, Willows RD, (2011) Mammalian forebrain ketimine reductase identified as μ-crystallin; potential regulation by thyroid hormones. J Neurochem 118, 379-387.
7. Cavallini D, Ricci G, Duprè S, Pecci L, Costa M, Matarese RM, Pensa B, Antonucci A, Solinas SP, &, Fontana M, (1991) Sulfur-containing cyclic ketimines and imino acids. A novel family of endogenous products in the search for a role. Eur J Biochem 202, 217-223.
8. Visser WE, Wong WS, van Mullem AA, Friesema EC, Geyer J, &, Visser TJ, (2010) Study of the transport of thyroid hormone by transporters of the SLC10 family. Mol Cell Endocrinol 315, 138-145.
9. Al-Kafaji G, &, Malik AN, (2010) Hyperglycemia induces elevated expression of thyroid hormone binding protein in vivo in kidney and heart and in vitro in mesangial cells. Biochem Biophys Res Commun 391, 1585-1591.
10. Reed PW, Corse AM, Porter NC, Flanigan KM, &, Bloch RJ, (2007) Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy. Exp Neurol 205, 583-586. (Pubitemid 46755775)
11. Abe S, Katagiri T, Saito-Hisaminato A, Usami S, Inoue Y, Tsunoda T, &, Nakamura Y, (2003) Identification of CRYM as a candidate responsible for nonsyndromic deafness, through cDNA microarray analysis of human cochlear and vestibular tissues. Am J Hum Genet 72, 73-82. (Pubitemid 36056843)
12. Oshima A, Suzuki S, Takumi Y, Hashizume K, Abe S, &, Usami S, (2006) CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea. J Med Genet 43, e25.
13. Malinowska K, Cavarretta IT, Susani M, Wrulich OA, Überall F, Kenner L, &, Culig Z, (2009) Identification of μ-crystallin as an androgen-regulated gene in human prostate cancer. Prostate 69, 1109-1118.
14. Lovell SC, Davis IW, Arendall WB 3rd, de Bakker PI, Word JM, Prisant MG, Richardson JS, &, Richardson DC, (2003) Structure validation by Calpha geometry: phi, psi and Cbeta deviation. Proteins 50, 437-450.
15. Gallagher DT, Monbouquette HG, Schröder I, Robinson H, Holden MJ, &, Smith NN, (2004) Structure of alanine dehydrogenase from Archaeoglobus: active site analysis and relation to bacterial cyclodeaminase and mammalian mu crystalline. J Mol Biol 342, 119-130. (Pubitemid 39094509)
16. Goodman JL, Wang S, Alam S, Ruzicka FJ, Frey PA, &, Wedekind JE, (2004) Ornithine cyclodeaminase: structure, mechanism of action, and implications for the μ-crystallin family. Biochemistry 43, 13883-13891. (Pubitemid 39482737)
17. Cheng Z, Sun L, He J, &, Gong W, (2007) Crystal structure of human μ-crystallin complexed with NADPH. Protein Sci 16, 329-335. (Pubitemid 46155782)
18. Laskowski RA, &, Swindells MB, (2011) LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 51, 2778-2786.
19. The PyMOL Molecular Graphics System, Version 1.5.0.4. Schrödinger LLC, New York.
20. Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, &, Coleman RG, (2012) ZINC: a free tool to discover chemistry for biology. J Chem Inf Model 52, 1757-1768.
21. Beslin A, Vié M-P, Blondeau J-P, &, Francon J, (1995) Identification by photoaffinity labelling of a pyridine nucleotide-dependent tri-iodothyronine-binding protein in the cytosol of cultured astroglial cells. Biochem J 305, 729-737.
22. Girard M, Turgeon SL, &, Gauthier SF, (2003) Quantification of the interactions between beta-lactoglobulin and pectin through capillary electrophoresis analysis. J Agric Food Chem 51, 6043-6049.
23. Chowdhury EK, Saitoh T, Nagata S, Ashiuchi M, &, Misono H, (1998) Alanine dehydrogenase from Enterobacter aerogenes: purification, characterization, and primary structure. Biosci Biotechnol Biochem 62, 2357-2363. (Pubitemid 128474929)
24. Ohshima T, Sakane M, Yamazaki T, &, Soda K, (1990) Thermostable alanine dehydrogenase from thermophilic Bacillus sphaericus DSM 462. Purification, characterization and kinetic mechanism. Eur J Biochem 191, 715-720. (Pubitemid 20265782)
25. + and NADPH in the activity and structure of GDP-D-mannose 4,6 dehydratase from two chlorella viruses. J Biol Chem 283, 184-193.
26. McCarthy K, Lovenberg W, &, Sjoerdsma A, (1968) The mechanism of inhibition of horse liver alcohol dehydrogenase by thyroxine and related compounds. J Biol Chem 243, 2754-2760.
27. Kabsch W, (1993) Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J Appl Crystallogr 26, 795-800.
28. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, &, Read RJ, (2007) Phaser crystallographic software. J Appl Crystallogr 40, 658-674. (Pubitemid 47080256)
29. Emsley P, &, Cowtan K, (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D60, 2126-2132. (Pubitemid 41742764)
30. Murshudov GN, Vagin AA, &, Dodson EJ, (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D53, 240-255. (Pubitemid 27235885)
31. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, et al,. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D66, 213-221.
32. Hooft RW, Vriend G, Sander C, &, Abola EE, (1996) Errors in protein structures. Nature 381, 272.
33. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, et al,. (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47, 1739-1749. (Pubitemid 38380917)